BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 15671963)

  • 1. Antifungal drugs.
    Treat Guidel Med Lett; 2005 Feb; 3(30):7-14. PubMed ID: 15671963
    [No Abstract]   [Full Text] [Related]  

  • 2. Antifungal drugs.
    Treat Guidel Med Lett; 2008 Jan; 6(65):1-8. PubMed ID: 18157085
    [No Abstract]   [Full Text] [Related]  

  • 3. The value of amphotericin B in the treatment of invasive fungal infections.
    Klepser M
    J Crit Care; 2011 Apr; 26(2):225.e1-10. PubMed ID: 20951541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction to antifungal drugs.
    Dismukes WE
    Clin Infect Dis; 2000 Apr; 30(4):653-7. PubMed ID: 10770726
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antifungals for systemic use].
    Ruiz-Camps I; Cuenca-Estrella M
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):353-62. PubMed ID: 19482382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options for invasive fungal infections.
    Dodds Ashley ES
    Pharmacotherapy; 2006 Jun; 26(6 Pt 2):55S-60S. PubMed ID: 16716123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic antifungal drugs.
    Med Lett Drugs Ther; 1996 Feb; 38(967):10-2. PubMed ID: 8559113
    [No Abstract]   [Full Text] [Related]  

  • 8. Recent approaches to antifungal therapy for invasive mycoses.
    Mathew BP; Nath M
    ChemMedChem; 2009 Mar; 4(3):310-23. PubMed ID: 19170067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of systemic fungal infections in older patients: achieving optimal outcomes.
    Kauffman CA; Hedderwick SA
    Drugs Aging; 2001; 18(5):313-23. PubMed ID: 11392440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy with amphotericin B and other new antifungal agents.
    Riley HD
    J Okla State Med Assoc; 1974 Apr; 67(4):141-5. PubMed ID: 4596788
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antimycotic therapy].
    Schaffner A
    Ther Umsch; 1990 Aug; 47(8):664-9. PubMed ID: 2218968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amphotericin B: the end of an era].
    Oude Lashof AM; Kullberg BJ
    Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1665-8. PubMed ID: 15453116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphotericin B deoxycholate: no significant advantage of a 24 h over a 6 h infusion schedule.
    Altmannsberger P; Holler E; Andreesen R; Krause SW
    J Antimicrob Chemother; 2007 Jul; 60(1):180-2. PubMed ID: 17537868
    [No Abstract]   [Full Text] [Related]  

  • 14. Drugs for treatment of systemic fungal infections.
    Med Lett Drugs Ther; 1986 Apr; 28(711):41-4. PubMed ID: 3959988
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of amphotericin B with azole antifungal drugs: what are we doing?
    Sugar AM
    Antimicrob Agents Chemother; 1995 Sep; 39(9):1907-12. PubMed ID: 8540690
    [No Abstract]   [Full Text] [Related]  

  • 16. Drugs for treatment of systemic fungal infections.
    Med Lett Drugs Ther; 1984 Mar; 26(658):36-8. PubMed ID: 6321929
    [No Abstract]   [Full Text] [Related]  

  • 17. [Review article. Molecular basis of antimycotic therapy].
    Bastert J; Korting HC
    Mycoses; 1999; 42 Suppl 1():73-9. PubMed ID: 10592721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs for treatment of deep fungal infection.
    Med Lett Drugs Ther; 1988 Mar; 30(761):30-2. PubMed ID: 3343965
    [No Abstract]   [Full Text] [Related]  

  • 19. Is there a role for polyenes in treating invasive mycoses?
    Cornely OA; Vehreschild JJ; Ullmann AJ
    Curr Opin Infect Dis; 2006 Dec; 19(6):565-70. PubMed ID: 17075332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selecting antifungal agents for the treatment of invasive fungal infections in patients with renal failure.
    Moudgal VV; Sobel JD
    Curr Opin Investig Drugs; 2004 Aug; 5(8):873-8. PubMed ID: 15600244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.